Innovative Cardiovascular Solutions
About Innovative Cardiovascular Solutions
At ICS, we strive to develop novel solutions that offer full protection from embolic material released during left-sided heart procedures. With our first product, the Emblok Embolic Protection System, our goal is to improve patient quality of life and lower overall healthcare costs that are associated with embolic risks.YEAR FOUNDED:
2012
LEADERSHIP:
CEO: R. Kevin Plemmons
CSO: William Merhi
COO: Greg Davis
CFO: Shayne E. Plemmons
3 articles about Innovative Cardiovascular Solutions
-
Innovative Cardiovascular Systems Announces First Use of its Next-Generation Emblok™ Embolic Protection System in European Feasibility Study
3/5/2019
New System Significantly Increases Percentage of Patients Able to Receive Embolic Protection
-
Innovative Cardiovascular Solutions Raises $5.0 Million In Series B Financing For Advanced Device Development And Initiation Of U.S. Clinical Activities
7/11/2017
-
Innovative Cardiovascular Solutions Announces Successful First Cases In European Clinical Study Of EMBLOK Embolic Protection System
3/16/2017